Clinical trial
Bupropion for Hospital-Based Smoking Cessation
NCT00261170 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00261170 |
|---|---|
| Title | Bupropion for Hospital-Based Smoking Cessation |
| Official title | Bupropion for Hospital-Based Smoking Cessation |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking |
| Intervention type | Drug, Other |
| Interventions | bupropion, placebo |
| Enrollment | 85 |
| Start date | Jul 1, 2003 |
| Primary completion | Aug 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Dec 2, 2005 |
| Last update posted | May 23, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: